Scientists Who Selfie: Building Public Trust Through Social Media

JEFF ATKINS | May 10, 2019 | 43 views

There are many ways to communicate science, but few as expedient and direct as social media. But while Twitter and Instagram have given scientists unprecedented, unfiltered reach to new audiences, there has been a desire to understand how scientists who use those platforms are perceived by those audiences. A recent paper published in PLOS ONE details results from the Scientists of Instagram project which highlights how real-life scientists share their work and lives via Instagram and how they are perceived by survey respondents.

Spotlight

The Science Advisory Board

The Science Advisory Board is a global community of scientists and medical professionals from around the world. Manufacturers of laboratory instruments and consumables, pharmaceutical and medical device companies, financial institutions and government agencies rely on the perspectives of our members when making important decisions.

OTHER ARTICLES
MEDTECH

Next-Gen Gene Therapy to Counter Complex Diseases

Article | September 22, 2022

Gene therapy has historically been used to treat disorders with in-depth knowledge caused by a single genetic mutation. Thanks to the introduction of new generation technologies, the potential of gene therapy is expanding tAo treat diseases that were previously untreatable. Evolution of Gene Therapy One of the major success stories of the twenty-first century has been gene therapy. However, it has not been the same in the past. The field's journey to this point has been long and mostly difficult, with both tragedy and triumph along the way. Initially, genetic disorders were thought to be untreatable and permanently carved into the genomes of individuals unfortunate enough to be born with them. But due to the constant technological advancement and research activities, gene therapy now has the potential to treat various genetic mutation-causing diseases with its ability to insert a new copy and replace faulty genes. Gene Therapy is Finding New Roads in the Medical Sector Gene therapy can help researchers treat a variety of conditions that fall under the general heading of epilepsy, instead of only focusing on a particular kind of disorder brought on by a genetic mutation. Following are some of the domains transformed by gene therapy. Neurology – Gene therapy can be used for the treatment of seizures by directly injecting it into the area causing an uncontrolled electrical disturbance in the brain. Furthermore, by using DNA sequences known as promoters, gene therapy can be restricted to specific neurons within that area. Ophthalmology – Genetic conditions such as blindness can be caused due to the mutation of any gene out of over 200 and resulting in progressive vision loss in children. With advanced gene therapies such as optogenetics, lost photoreceptor function can be transferred to the retinal cells, which are responsible for relaying visual information to the brain. This might give patients the ability to navigate in an unknown environment with a certain level of autonomy. The Future of Gene Therapy The news surrounding gene therapy has been largely favorable over the past few years, with treatment after treatment obtaining regulatory approvals, successful clinical trials, and garnering significant funds to begin development. With more than 1,000 clinical trials presently underway, the long-awaited gene therapy revolution might finally be here.

Read More
RESEARCH

Expansion of BioPharma: Opportunities and Investments

Article | July 11, 2022

Biopharmaceutical innovations are among the most ingenious and refined achievements of modern medical science. New concepts, techniques, and therapies are emerging, such as the cell therapy Provenge, which can be used to treat cancer, and gene therapies, which provide even more amazing promises of disease remission and regenerative medicine. In addition, the COVID-19 pandemic has caused a huge boom in the pharmaceutical industry. This is because more and more attention is being paid to increasing manufacturing capacity and starting new research on drug development. Biopharma: Leading the Way in the Pharma Sector In the past couple of years, the biopharmaceutical sector has deepened its roots across the medical and pharmaceutical industries, on account of the transformation of pharmaceutical companies towards biotechnology, creating opportunities for growth. Also, growing advancements in technologies such as 3D bioprinting, biosensors, and gene editing, along with the integration of advanced artificial intelligence and virtual and augmented reality are estimated to further create prospects for growth. According to a study, the biopharmaceutical sector makes nearly $163 billion around the world and grows by more than 8% each year, which is twice as fast as the traditional pharma sector. Massive Investments Directed Towards Biopharma Investing in biotech research and development (R&D) has yielded better returns than the pharma industry average. Hence, a number of pharmaceutical companies are shifting their presence toward biopharma to capitalize on the upcoming opportunities by investing in and expanding their biotechnology infrastructure. For instance, Thermo Fisher Scientific Inc., an American manufacturer of scientific instrumentation, reagents and consumables, and software services, announced an investment of $97 million to expand its bioanalytical laboratory operations into three new locations in the U.S. With this investment, the company will add 150,000 square feet of scientific workspace and install the most advanced drug development technologies to produce life-changing medicines for patients in need.

Read More
MEDTECH

2022 U.S. Market Research Report with COVID-19 Forecasts2

Article | July 5, 2022

The global biotechnology market is expected to grow at a compound annual growth rate (CAGR) of 13.9 percent from 2022 to 2030, with a value estimated at USD 1,023.92 billion in 2021. The market is being propelled by strong government support in the form of initiatives aimed at modernizing the regulatory framework, improving approval processes and reimbursement policies, and standardizing clinical studies. The growing presence of personalized medicine and an increasing number of orphan drug formulations are opening up new avenues for biotechnology applications and driving the influx of emerging and innovative biotechnology companies, which is driving market revenue even further. The 2022 Biotech Research and Development Market Research Report is one of the most comprehensive and in-depth assessments of the industry in the United States, containing over 100 data sets spanning the years 2013 to 2026. This Kentley Insights report contains historical and forecasted market size, product lines, profitability, financial ratios, BCG matrix, state statistics, operating expense details, organizational breakdown, consolidation analysis, employee productivity, price inflation, pay bands for the top 20 industry jobs, trend analysis and forecasts on companies, locations, employees, payroll, and much more. Companies in the Biotech Research and Development industry are primarily engaged in biotechnology research and experimental development. Biotechnology research and development entails the investigation of the use of microorganisms and cellular and bimolecular processes to create or modify living or non-living materials. This biotechnology research and development may result in the development of new biotechnology processes or prototypes of new or genetically altered products that can be replicated, used, or implemented by various industries. This report was created using the findings of extensive business surveys and econometrics. The professionals follow reports with accurate and apt information on market sizing, benchmarking, strategic planning, due diligence, cost-cutting, planning, understanding industry dynamics, forecasting, streamlining, gap analysis, and other ana

Read More
MEDTECH

Biotech in 2022

Article | July 11, 2022

The robust global channel of more than, 800 gene and cell curatives presently in trials will produce clinical readouts in 2022, revealing what lies ahead for advanced curatives. The impact will be felt in 2022, no matter how you slice it. Eventually, how well industry and non-supervisory bodies unite to produce new frameworks for advanced therapies will shape the year 2022 and further. Pacific Northwest talent will continue to contribute to the advancement of gene and cell curatives in both the short and long term, thanks to its deep pool of ground-breaking scientific developers, entrepreneurial directorial leadership, largely skilled translational scientists, and endured bio manufacturing technicians. We may see continued on-life science fund withdrawal from biotech in 2021, but this can be anticipated as a strong comeback in 2022 by biotech industry, backed by deep-pocketed life science investors who are committed to this sector. A similar investment, combined with pharma's cash-heavy coffers, can result in increased junction and acquisition activity, which will be a challenge for some but an occasion for others. Over the last five years, investment interest in Seattle and the Pacific Northwest has grown exponentially, from Vancouver, British Columbia, to Oregon. The region's explosive portfolio of new biotech companies, innovated out of academic centres, demonstrates the region's growing recognition of scientific invention. This created a belief that continued, especially because Seattle's start-ups and biotech enterprises are delivering on their pledge of clinical and patient impact. Talent and staffing will continue to be difficult to find. It's a CEO's market, but many of these funds' return, and are not rising in proportion to the exorbitant prices they're paying to enter deals. This schism has become particularly pronounced in 2021. Hence, everyone in biotech is concerned about reclamation and retention.

Read More

Spotlight

The Science Advisory Board

The Science Advisory Board is a global community of scientists and medical professionals from around the world. Manufacturers of laboratory instruments and consumables, pharmaceutical and medical device companies, financial institutions and government agencies rely on the perspectives of our members when making important decisions.

Related News

New species of flying squirrel from Southwest China added to the rarest and most wanted

phys.org | July 18, 2019

Described in 1981, the genus Biswamoyopterus is regarded as the most mysterious and rarest amongst all flying squirrels. It comprises two large 1.4-1.8 kg species endemic to southern Asia the Namdapha flying squirrel (India) and the Laotian giant flying squirrel (Lao PDR). Each is only known from a single specimen discovered in 1981 and 2013, respectively. Recently, in 2018, a specimen identifiable as Biswamoyopteruswas unexpectedly found in the collections of the Kunming Institute of Zoology (KIZ), Chinese Academy of Sciences by in-house expert Quan Li. It had been collected from Mount Gaoligong in Yunnan Province, Southwest China. Initially, the individual was considered to belong to the "missing" Namdapha flying squirrel: a species considered as critically endangered due to hunting and habitat loss. The latter had not ever been recorded since its original description in 1981 and was already listed as one of the top 25 "most wanted" species in the world by the Global Wildlife Conservation.

Read More

Tornadoes, windstorms pave way for lasting plant invasions

phys.org | July 18, 2019

When tornadoes touch down, we brace for news of property damage, injuries, and loss of life, but the high-speed wind storms wreak environmental havoc, too. They can cut through massive swaths of forest, destroying trees and wildlife habitat, and opening up opportunities for invasive species to gain ground. A new University of Illinois study, published in the Journal of Ecology, shows that large blowdown areas in southern Illinois forests are more heavily invaded and slower to recover than smaller areas. The research guides management decisions for windstorm-prone forests. "We used satellite imagery and grueling on-the-ground surveys to look at what was happening with invasive plants after a series of windstorms—a tornado in 2006, a derecho in 2009, and another tornado in 2017—hit southern Illinois forests," says Eric Larson, assistant professor in the Department of Natural Resources and Environmental Sciences at U of I and co-author on the study. "We assume the forest recovers and those invaders get shaded out, but they may not. They could potentially prevent forest recovery or spread into surrounding areas."

Read More

Little genes, big conservation: Scientists study genetic rescue

phys.org | July 17, 2019

At first glance, there arent many similarities between westslope cutthroat trout in Montana, wolves on Isle Royale National Park in Michigan and Australias mountain pygmy possum, a mouse-sized alpine marsupial. With all three, though, managers have attempted or explored the possibility of genetic rescue, a conservation approach that involves moving a small number of individual animals from one population to another to reduce genetic problems and decrease extinction risk. Now, a new paper by University of Montana scientists examines the potential and uncertainties of attempting genetic rescue. The peer-reviewed paper, published this month in the journal Trends in Ecology and Evolution, is a synthesis and summary of the state of genetic rescue. In this opinion piece, the authors focus on what is unknown about genetic rescue and where research could go in the future. The authors define genetic rescue as a decrease in population extinction probability owing to gene flow, best measured as in increase in population growth.

Read More

New species of flying squirrel from Southwest China added to the rarest and most wanted

phys.org | July 18, 2019

Described in 1981, the genus Biswamoyopterus is regarded as the most mysterious and rarest amongst all flying squirrels. It comprises two large 1.4-1.8 kg species endemic to southern Asia the Namdapha flying squirrel (India) and the Laotian giant flying squirrel (Lao PDR). Each is only known from a single specimen discovered in 1981 and 2013, respectively. Recently, in 2018, a specimen identifiable as Biswamoyopteruswas unexpectedly found in the collections of the Kunming Institute of Zoology (KIZ), Chinese Academy of Sciences by in-house expert Quan Li. It had been collected from Mount Gaoligong in Yunnan Province, Southwest China. Initially, the individual was considered to belong to the "missing" Namdapha flying squirrel: a species considered as critically endangered due to hunting and habitat loss. The latter had not ever been recorded since its original description in 1981 and was already listed as one of the top 25 "most wanted" species in the world by the Global Wildlife Conservation.

Read More

Tornadoes, windstorms pave way for lasting plant invasions

phys.org | July 18, 2019

When tornadoes touch down, we brace for news of property damage, injuries, and loss of life, but the high-speed wind storms wreak environmental havoc, too. They can cut through massive swaths of forest, destroying trees and wildlife habitat, and opening up opportunities for invasive species to gain ground. A new University of Illinois study, published in the Journal of Ecology, shows that large blowdown areas in southern Illinois forests are more heavily invaded and slower to recover than smaller areas. The research guides management decisions for windstorm-prone forests. "We used satellite imagery and grueling on-the-ground surveys to look at what was happening with invasive plants after a series of windstorms—a tornado in 2006, a derecho in 2009, and another tornado in 2017—hit southern Illinois forests," says Eric Larson, assistant professor in the Department of Natural Resources and Environmental Sciences at U of I and co-author on the study. "We assume the forest recovers and those invaders get shaded out, but they may not. They could potentially prevent forest recovery or spread into surrounding areas."

Read More

Little genes, big conservation: Scientists study genetic rescue

phys.org | July 17, 2019

At first glance, there arent many similarities between westslope cutthroat trout in Montana, wolves on Isle Royale National Park in Michigan and Australias mountain pygmy possum, a mouse-sized alpine marsupial. With all three, though, managers have attempted or explored the possibility of genetic rescue, a conservation approach that involves moving a small number of individual animals from one population to another to reduce genetic problems and decrease extinction risk. Now, a new paper by University of Montana scientists examines the potential and uncertainties of attempting genetic rescue. The peer-reviewed paper, published this month in the journal Trends in Ecology and Evolution, is a synthesis and summary of the state of genetic rescue. In this opinion piece, the authors focus on what is unknown about genetic rescue and where research could go in the future. The authors define genetic rescue as a decrease in population extinction probability owing to gene flow, best measured as in increase in population growth.

Read More

Events